Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

What the insiders did Net selling

By person

44 insiders · 172 transactions
22.2×

Geoff Martha holds 22.2 times base salary in stock. $31.15M of shares against $1.40M in salary for 2026.

Salary from the company's own proxy. The shares are what Geoff Martha last reported holding, valued at $95.00, the price Ordinary Shares was last bought or sold at on the open market here, on 15 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hooman Hakami
EVP & Group President Diabetes
—
$23.08M (14) scheduled
−$23.08M
30,761
0.0024%
$2.92M
−51.8%
Michael J Coyle
EVP & Group Pres, Cardiac&Vasc
—
$22.50M (8) scheduled
−$22.50M
190,390
0.0149%
$18.09M
+24.0%
Richard Kuntz
SVP & Chief Medical & Science
—
$21.31M (12) scheduled
−$21.31M
74,945
0.0059%
$7.12M
−33.6%
Bradley E Lerman
SVP General Counsel & Corp Sec
—
$20.33M (10) scheduled
−$20.33M
48,635
0.0038%
$4.62M
−15.1%
Omar Ishrak
Executive Chairman
$2.01M (2)
$19.41M (3) scheduled
−$17.41M
575,582
0.0450%
$54.68M
+0.4%
Geoffrey Martha
Chairman and CEO
—
$16.65M (10) scheduled
−$16.65M
277,866
0.0217%
$26.40M
+326.7%
Robert John White
EVP & Pres. Medical Surgical
—
$13.47M (11) scheduled
−$13.47M
49,910
0.0039%
$4.74M
+2.6%
Hoedt Rob Ten
EVP and Pres. Global Regions
—
$8.49M (8) scheduled
−$8.49M
52,748
0.0041%
$5.01M
−5.0%
Sean Salmon
EVP & President Cardiovascular
—
$7.76M (6) scheduled
−$7.76M
64,722
0.0051%
$6.15M
+123.2%
Harry Skip Kiil
EVP & President Cardiovascular
—
$6.40M (10) scheduled
−$6.40M
42,186
0.0033%
$4.01M
+21.3%
Carol A Surface
EVP, Chief HR Officer
—
$5.34M (6)
−$5.34M
26,725
0.0021%
$2.54M
−56.0%
Bryan C Hanson
EVP, President, MITG
—
$4.90M (4)
−$4.90M
88,818
0.0069%
$8.44M
−43.0%
John R Liddicoat
EVP & President of Americas
—
$4.39M (1) scheduled
−$4.39M
37,374
0.0029%
$3.55M
−13.6%
Gregory L Smith
EVP Global Ops & Supply Chain
—
$3.90M (8)
−$3.90M
46,016
0.0036%
$4.37M
+36.6%
Richard H Anderson
Director
$3.34M (6)
—
+$3.34M
113,023
0.0088%
$10.74M
+63.1%
Brett A. Wall
EVP & Pres Neuroscience
—
$2.91M (8) scheduled
−$2.91M
82,183
0.0064%
$7.81M
+356.1%
Michael Marinaro
President
—
$1.19M (3) scheduled
−$1.19M
113,353
0.0089%
$10.77M
+309.6%
Robert C Pozen
Director
$999.98K (1)
$308.74K (1) scheduled
+$691.24K
60,964
0.0048%
$5.79M
+11.6%
William R Jellison
Director
$462.75K (2)
—
+$462.75K
6,444
0.0005%
$612.18K
—
Matthew R. Walter
SVP, Chief HR Officer
—
$257.93K (1) scheduled
−$257.93K
39,928
0.0031%
$3.79M
+114.8%
Karen L Parkhill
EVP & Chief Financial Officer
$251.61K (1)
$452.89K (6)
−$201.28K
96,589
0.0076%
$9.18M
+39.8%
James T Lenehan
Director
$146.53K (1)
$109.12K (1) scheduled
+$37.41K
57,849
0.0045%
$5.50M
+42.5%
Gary Lee Ellis
EVP & Global Ops and IT
—
—
—
180,718
0.0141%
$17.17M
−5.2%
Randall J Hogan
Director
—
—
—
85,796
0.0067%
$8.15M
+56.2%
Denise M Oleary
Director
—
—
—
77,057
0.0060%
$7.32M
+30.8%
Ivan K Fong
EVP General Counsel & Secr
—
—
—
54,692
0.0043%
$5.20M
+1,879%
Kendall J Powell
Director
—
—
—
51,380
0.0040%
$4.88M
+43.9%
Thierry Pieton
EVP & Chief Financial Officer
—
—
—
49,645
0.0039%
$4.72M
+2,944%
Gary Louis Corona
Interim CFO
—
—
—
44,255
0.0035%
$4.20M
+79.6%
Craig Arnold
Director
—
—
—
42,185
0.0033%
$4.01M
+130.8%
Shirley A Jackson
Director
—
—
—
38,525
0.0030%
$3.66M
+8.5%
Kweli Thompson
EVP & President, Neuroscience
—
—
—
35,390
0.0028%
$3.36M
+17.2%
Jennifer M Kirk
Chief Accounting Officer
—
—
—
28,011
0.0022%
$2.66M
+206.1%
Michelle Quinn
EVP, GC and Secretary
—
—
—
26,721
0.0021%
$2.54M
+3,734%
Scott C Donnelly
Director
—
—
—
23,679
0.0019%
$2.25M
+199.5%
Michael O Leavitt
Director
—
—
—
21,779
0.0017%
$2.07M
+75.2%
Elizabeth G Nabel
Director
—
—
—
19,584
0.0015%
$1.86M
+413.9%
Denise L. Blomquist
Chief Accounting Officer
—
—
—
16,398
0.0013%
$1.56M
+105.1%
Andrea Jo Goldsmith
Director
—
—
—
10,247
0.0008%
$973.47K
+2,762%
Kevin E Lofton
Director
—
—
—
9,977
0.0008%
$947.82K
+3,248%
Lidia Fonseca
Director
—
—
—
7,644
0.0006%
$726.18K
+3,007%
Gregory P Lewis
Director
—
—
—
5,754
0.0004%
$546.63K
+4,431%
Joon Sup Lee
Director
—
—
—
1,803
0.0001%
$171.29K
—
John P Groetelaars
Director
—
—
—
1,444
0.0001%
$137.18K
—